Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexxar + ASCT in Older Relapsed/Refractory NHL
NCT00073931Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Oct 1999
- Primary completion
- May 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tositumomab in non-Hodgkin lymphoma (NHL), sponsored by Fred Hutchinson Cancer Center. Primary endpoint: Progression-Free Survival. Started Oct 1999; status: completed.
02
Drugs
tositumomab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00073931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073931.